Scientists discovered a sequence that could produce up to 10 times as many proteins as unoptimized tail sequences, which are commonly used for synthetic mRNAs on both human cells and on mice. There is also a doubling of the duration of production.
TThis new technology will reduce the amount and number of injections needed for drugs and vaccines, but it will also potentially lower the cost of treatments. Along with other technologies, it can be used to synergically boost the production of genes.